PPARG and non-small cell lung carcinoma: This beneficial effect has also been observed in NSCLC cells, where induction of PPARα inhibited growth and angiogenesis, as well as leading to apoptosis in ovarian cancer cells when combined with PPARγ induction (162, 163).